Clinical Trial Update: Post-marketing Surveillance (Special Use-results Surveillance) on Use With Liraglutide (Victoza®)

View source ↗

Summary

A completed post-marketing surveillance trial evaluating the safety of using liraglutide (Victoza) in patients with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Victoza (Liraglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Status: COMPLETED